Proxy Results (Form 8-K)

On October 31, 2025 at 12:00 p.m. Eastern Time, Glucotrack, Inc. (the "Company") convened and then adjourned its special meeting of the stockholders (the "Meeting"). The only proposal submitted for a vote of the stockholders at the Meeting was the approval of the adjournment of such meeting (the "Adjournment Proposal").

As of the close of business, on September 23, 2025, the record date for the Meeting, there were 899,410 shares of common stock outstanding and entitled to vote, 16.4% of which shares were represented in person or by proxy at the Meeting, which did not constitute a quorum to conduct business.

As described in detail in the definitive proxy statement (the "Proxy Statement") related to the Meeting filed by the Company with the Securities and Exchange Commission on October 3, 2025, the Adjournment Proposal was presented to stockholders at the Meeting to seek their approval to adjourn the Meeting to another time to solicit additional proxies to obtain sufficient votes to constitute a quorum.

The following is a tabulation of the votes with respect to the Adjournment Proposal, which was approved by the Company's stockholders:

Approval of the Adjournment Proposal

The Meeting has been adjourned to November 7, 2025 at 12:00 p.m. Eastern Time (the "Adjourned Meeting"). You are permitted to attend the Adjourned Meeting online at https://www.virtualshareholdermeeting.com/GCTK2025M2.

At the Adjourned Meeting, stockholders will be asked to vote on the Issuance Proposal, as described in detail in the Proxy Statement.